Judge Won't Cull EpiPen Antitrust Action Against Mylan
By Nadia Dreid · December 10, 2024, 10:25 PM EST
Mylan Pharmaceuticals didn't get the early exit it sought from litigation accusing it of working with Pfizer to inflate the price of the latter's popular auto-injecting emergency allergy medication EpiPen, as a...
To view the full article, register now.